Back to Journals » Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
- View all (694)
- Volume 19, 2026 (6)
- Volume 18, 2025 (23)
- Volume 17, 2024 (44)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Journal Articles:
- 694 records -
Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report
Xu R, Zhang M, Zeng Z, Wei Y, Liao X, Yang C, Peng T, Su H
Pharmacogenomics and Personalized Medicine 2026, 19:578577
Published Date: 7 April 2026
Construction and Validation of Multi-Omics Predictive Models for Colorectal Cancer Using Machine-Learning Approaches
Lu Z, Li X, Liang Z, Zhang X, Tan Y, Kuang Y, Li K, Zhu X
Pharmacogenomics and Personalized Medicine 2026, 19:566928
Published Date: 2 April 2026
NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
Khan N, Jonnalagadda M, Kumar R, Das A
Pharmacogenomics and Personalized Medicine 2026, 19:568037
Published Date: 10 March 2026
Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma
Li S, Zhang C, Lv S, Zhang Z, Xu D, Xu T
Pharmacogenomics and Personalized Medicine 2026, 19:562602
Published Date: 17 February 2026
Post-Translational Modifications of Histones and Non-Histones in Liver Disease and Traditional Chinese Medicine Treatment: A Narrative Review
Xie Z, Deng Y, Zhang X, Chen J, Deng J, Fang Y, Ye X, Zhou Z
Pharmacogenomics and Personalized Medicine 2026, 19:555701
Published Date: 3 February 2026
Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study
Han R, Yu X
Pharmacogenomics and Personalized Medicine 2026, 19:566952
Published Date: 3 February 2026
Managing Refractory Hypertension: A Case Study Exploring the Influence of ACE and ACTN3 Gene Polymorphisms
Gasser B, Dössegger A, Flück M
Pharmacogenomics and Personalized Medicine 2025, 18:287-294
Published Date: 19 December 2025
Case Report: Successful Surgical Resection of PVTT Vp4 Hepatocellular Carcinoma Following Hepatic Arterial Infusion Chemotherapy Combined with Cadonilimab Plus Donafenib
Chen S, Wei Y, Liao X, Yang C, Zhu G, Han C, Su H, Peng T
Pharmacogenomics and Personalized Medicine 2025, 18:279-286
Published Date: 6 December 2025
Berberine Repairs Intestinal Mucosal Barrier by Targeting HSP90AA1 and MAPK14
Zhao D, Zhai Y, Chen C, Chen J, Chen D, Yang Q, Yu Z, Shao S, Huang Y, Shu J
Pharmacogenomics and Personalized Medicine 2025, 18:263-278
Published Date: 15 November 2025
Genetic Landscape of VIP Pharmacogenomic Variants in the Kinh Vietnamese Population
Tong H, Phan VTN, Nguyen T, Le L
Pharmacogenomics and Personalized Medicine 2025, 18:251-261
Published Date: 14 October 2025
Whole Exome Sequencing Reveals Novel Genetic Variants Associated with Atrial Septal Defect in a Tibetan Patient Cohort
Li H, He Y, Cai Z, Che Q, Wu Y, Zhou M, He Z, Zhao L
Pharmacogenomics and Personalized Medicine 2025, 18:239-250
Published Date: 10 September 2025
Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies
Bu S, Cheng X, Chen M, Yu Y
Pharmacogenomics and Personalized Medicine 2025, 18:219-238
Published Date: 5 September 2025
Association Between ABCB1 Gene Polymorphism with Hyperglycemia and MACE in Patients Undergoing Clopidogrel Treatment After PCI
Zhou B, Shi C, Xu Q, Wei Y, Zhang S, Wang X, An X
Pharmacogenomics and Personalized Medicine 2025, 18:209-217
Published Date: 25 August 2025
The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data
Wittwer NL, Meier CR, Huber CA, Moser JD, Meyer zu Schwabedissen HE, Allemann SS, Schneider C
Pharmacogenomics and Personalized Medicine 2025, 18:197-208
Published Date: 23 August 2025
Dual EGFR L858R and KRAS G12A Mutations in Lung Adenocarcinoma: A Rare Case Report and Literature Review
Wei G, Tang J, Wang H, Zhang D
Pharmacogenomics and Personalized Medicine 2025, 18:189-196
Published Date: 22 August 2025
Construction of a Nomogram Model for Predicting Prognosis in Breast Cancer Patients Based on the Expression of THRSP and ACACA Proteins Tissues
Wei B, Li F, Yan H, Shen J
Pharmacogenomics and Personalized Medicine 2025, 18:179-188
Published Date: 31 July 2025
Advances in the Clinical Use of Clopidogrel: A Review of Individualized Treatment Strategies and Monitoring Optimization Based on Genetic Polymorphisms
Dou N, Ma H, Zhang P, Lu R, Hang J, Sun J
Pharmacogenomics and Personalized Medicine 2025, 18:163-177
Published Date: 9 July 2025
Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
Chen Q, Zhang W, Zha L
Pharmacogenomics and Personalized Medicine 2025, 18:153-162
Published Date: 17 June 2025
Associations Between FTO Polymorphisms and Neuroblastoma Risk in Chinese Children
Liu P, Li Y, Li Y, Li L, Cheng J, Li S, Zhang J, Zhou H, Huo Y, Yang Z, He J, Zhang R
Pharmacogenomics and Personalized Medicine 2025, 18:143-151
Published Date: 27 May 2025
Quercetin Inhibits Gastric Cancer Progression via FAM198B/MAPK Pathway Modulation
Deng H, Xiao Q, Xu X, Zhang L, Zhang Y
Pharmacogenomics and Personalized Medicine 2025, 18:115-141
Published Date: 15 May 2025
Prevalence of CYP2C19 Variants in Patients with Cardiovascular Disease from the Yunnan-Guizhou Plateau in Southwestern China
Li XP, Wang JL, Lei SX, Chen BY, Ma X, He F, Yue CF, Liu HX, Hu JP, Xiong Q, Ji T, Zhang ZF, Sun Y, Li HW
Pharmacogenomics and Personalized Medicine 2025, 18:105-113
Published Date: 2 May 2025
Clinicopathological and Molecular Features of Primary Inflammatory Myofibroblastic Tumor in Nasal Cavity and Paranasal Sinuses
Zhao Y, Ma D, Wan H, Piao Y
Pharmacogenomics and Personalized Medicine 2025, 18:95-104
Published Date: 28 April 2025
Novel SLC16A2 Frameshift Mutation as a Cause of Allan-Herndon-Dudley Syndrome and its Implications for Carrier Screening
Lin P, Liu H, Lou J, Lyu G, Li Y, He P, Fu Y, Zhang R, Zhang Y, Yan T
Pharmacogenomics and Personalized Medicine 2025, 18:85-94
Published Date: 23 April 2025
Pharmacogenomics of Chemotherapies for Childhood Cancers in Africa: A Scoping Review
Katabalo DM, Mwita S, Liwa AC, Kidenya BR, Schroeder K
Pharmacogenomics and Personalized Medicine 2025, 18:55-69
Published Date: 14 February 2025
Association of MiRNA Polymorphisms Involved in the PI3K/ATK/GSK3β Pathway with T2DM in a Chinese Population
Zhou X, Yang M, Yang Y, Xu F, Wang F, Jiao M, Tao W, Li Y
Pharmacogenomics and Personalized Medicine 2025, 18:71-84
Published Date: 14 February 2025
A Novel Pathogenic Splicing Mutation of OFD1 is Responsible for a Boy with Joubert Syndrome Exhibiting Orofaciodigital Spectrum Anomalies, Polydactyly and Retinitis Pigmentosa
Chen L, Zhao MF, Deng HW, Liao M, Fan LL, Zhong QB, Wang J, Li K, Wu ZH, Yin JY
Pharmacogenomics and Personalized Medicine 2025, 18:47-53
Published Date: 3 February 2025
Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway
Luo X, Chen L, Xu J, Li J
Pharmacogenomics and Personalized Medicine 2025, 18:35-46
Published Date: 31 January 2025
Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
Borbón A, Briceño JC, Valderrama-Aguirre A
Pharmacogenomics and Personalized Medicine 2025, 18:19-34
Published Date: 30 January 2025
Identification of Bacterial Lipopolysaccharide-Associated Genes and Molecular Subtypes in Autism Spectrum Disorder
He Y, He Y, Cheng B
Pharmacogenomics and Personalized Medicine 2025, 18:1-18
Published Date: 17 January 2025
PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Du P, Li X, Li D, Ma Y, Ni M, Li Y, Li W, Wang A, Xu X
Pharmacogenomics and Personalized Medicine 2024, 17:611-621
Published Date: 21 December 2024
The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward
Ram M, Fraser MR, Vieira dos Santos J, Tasakis R, Islam A, Abo-Donia JU, Parekh S, Lagana A
Pharmacogenomics and Personalized Medicine 2024, 17:573-609
Published Date: 21 December 2024
The Association of PLA2G7 Gene Polymorphisms with Serum Lp-PLA2 Activity and Lipid Profile in Han Chinese Patients with Coronary Heart Disease
Wang Y, Shi Y, Wu Z, Gao J, Wang J, Li L, Wan Y, Lang A M, Zhang J, Wang H, Hou Y
Pharmacogenomics and Personalized Medicine 2024, 17:563-572
Published Date: 21 December 2024
Associations Between the Polymorphisms in the Coding Sequence of SLCO1B1 and Blood Lipid Levels Before and After Treatment by Atorvastatin in the Chinese Han Adults with Dyslipidemia
Chen C, Tian Y, Jia F, Feng M, Zhang G, Li Q, Zhang Y, Sun N, Hu S, Ji Z
Pharmacogenomics and Personalized Medicine 2024, 17:551-561
Published Date: 20 December 2024
CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
Dong YM, Bao GQ
Pharmacogenomics and Personalized Medicine 2024, 17:535-550
Published Date: 17 December 2024
Prognostic Value and Immunological Role of POP7 in Clear Cell Renal Cell Carcinoma
Lou N, Meng X, Yu T, Li W, Lv X, Han W, Xiao W, Shi Y
Pharmacogenomics and Personalized Medicine 2024, 17:521-534
Published Date: 26 November 2024
Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis
Tang Y, He Y, Wu L
Pharmacogenomics and Personalized Medicine 2024, 17:511-520
Published Date: 20 November 2024
Immune Microenvironment Alterations and Identification of Key Diagnostic Biomarkers in Chronic Kidney Disease Using Integrated Bioinformatics and Machine Learning
Shi J, Xu A, Huang L, Liu S, Wu B, Zhang Z
Pharmacogenomics and Personalized Medicine 2024, 17:497-510
Published Date: 19 November 2024
Genetic Diversity Landscape in African Population: A Review of Implications for Personalized and Precision Medicine
Sibomana O
Pharmacogenomics and Personalized Medicine 2024, 17:487-496
Published Date: 11 November 2024
Pharmacogenomic Study of Selected Genes Affecting Amlodipine Blood Pressure Response in Patients with Hypertension
Jan A, Alanzi AR, Mothana RA, Kaimori JY, Ali SS, Muhammad T, Saeed M, Akbar R, Khan M
Pharmacogenomics and Personalized Medicine 2024, 17:473-486
Published Date: 29 October 2024
Bioinformatics-Based Identification of Key Prognostic Genes in Neuroblastoma with a Focus on Immune Cell Infiltration and Diagnostic Potential of VGF
Guo Q, Xiao Y, Chu J, Sun Y, Li S, Zhang S
Pharmacogenomics and Personalized Medicine 2024, 17:453-472
Published Date: 10 October 2024
Serum IFN-γ Predicts the Therapeutic Effect of Belimumab in Refractory Lupus Nephritis Patients
Liu S, Li J, Zhang Z, Meng D, Wang K
Pharmacogenomics and Personalized Medicine 2024, 17:443-452
Published Date: 30 September 2024
A Case Report of Hemiplegic Migraine with Mutation in the ATP1A2 Gene
Guan DM, Shan YZ, Zhao HT, Meng Y, Yan ZR, Zhang HL
Pharmacogenomics and Personalized Medicine 2024, 17:437-442
Published Date: 20 September 2024
TICRR Overexpression Enhances Disease Aggressiveness and Immune Infiltration of Cutaneous Melanoma
Chen C, Zou Y, Zheng X, Hu T, Ni J, Kan D, Yin Z, Ye L, Liu B
Pharmacogenomics and Personalized Medicine 2024, 17:423-435
Published Date: 3 September 2024
Acyl-CoA Thioesterase 8 (ACOT8) is a Poor Prognostic Biomarker in Breast Cancer
Wang Z, Wang H
Pharmacogenomics and Personalized Medicine 2024, 17:403-421
Published Date: 22 August 2024
Mitochondrial Diabetes May Not Be the Only Phenotypic Presentation of the m.5826A>G mtDNA Variant [Letter]
Finsterer J
Pharmacogenomics and Personalized Medicine 2024, 17:401-402
Published Date: 25 July 2024
M2 Macrophage Classification of Colorectal Cancer Reveals Intrinsic Connections with Metabolism Reprogramming and Clinical Characteristics
Huang F, Wang Y, Shao Y, Zhang R, Li M, Liu L, Zhao Q
Pharmacogenomics and Personalized Medicine 2024, 17:383-399
Published Date: 11 July 2024
Identification and Validation of Glycosylation-Related Genes in Obesity and MASH: Insights from Human Liver Samples and a High-Fat Diet Mouse Model
Yu W, Chen J, Jin S, Fan X, Cai X
Pharmacogenomics and Personalized Medicine 2024, 17:363-381
Published Date: 5 July 2024
The Role of Pharmacogenomics Studies for Precision Medicine Among Ethiopian Patients and Their Clinical Implications: A Scoping Review
Getahun KA, Angaw DA, Asres MS, Kahaliw W, Petros Z, Abay SM, Yimer G, Berhane N
Pharmacogenomics and Personalized Medicine 2024, 17:347-361
Published Date: 1 July 2024
Influence of Long Non-Coding RNAs on Human Oocyte Development
Wang L, Li B, Cheng D
Pharmacogenomics and Personalized Medicine 2024, 17:337-345
Published Date: 1 July 2024
Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD
Zhou Q, Liu Y, Gao Y, Quan L, Wang L, Wang H
Pharmacogenomics and Personalized Medicine 2024, 17:319-336
Published Date: 25 June 2024